PureTech Health plc (NASDAQ:PRTC) Q4 2024 Earnings Call Transcript
Operator: Greetings and welcome to the PureTech Health 2024 Year End Financial Results Conference. [Operator Instructions] As a reminder, this conference is being recorded.
Puretech Health Plc (PRTC)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Millennium Management Israel Englander | 44,911 | $859,821 | -1% | 0% |
| 2. | Pentwater Capital Management Matthew Halbower | 33,560 | $663,817 | +40% | 0.01% |
| 3. | Portolan Capital Management George Mccabe | 11,885 | $235,085 | 0.02% |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 302,000 | $560,349 | 0.03% | |
| 2. | 100 | $1,978 | 0% | |
| 3. | 20 | $396 | 0% | |
| 4. | 0 | $0 | 0% |
News See All
PureTech Health plc (NASDAQ:PRTC) Q2 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the PureTech Health 2024 Half Year Results Conference Call. At this time, all participants are in listen-only mode.
PureTech Health plc (NASDAQ:PRTC) Q4 2023 Earnings Call Transcript
Operator: Greetings, and welcome to the PureTech Health 2023 Year End Financial Results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.
10 Best Immunology Stocks to Invest In
Immunology is the study of the immune system of higher organisms in relation to disease.